Pharmaceutical Business Intelligence Reports
Showing 481–492 of 709 results
-
Excipient Business Development Opportunity Reports
PROPYL GALLATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PROPYLENE GLYCOL Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
PROPYLPARABEN Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QBREXZA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QNASL Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QSYMIA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QTERN Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QUARTETTE Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QULIPTA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QUTENZA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
QVAR REDIHALER Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
RADICAVA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart
